Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins

Contraception

Volumn 30, Issue 1, 1984, Pages 61-72

  Bergink, E W ^a   Kloosterboer, H J ^a   Lund, L ^b   Nummi, S ^b  

^a NV ORGANON   (Netherlands)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; DESOGESTREL; ETHINYLESTRADIOL; GLYCOSYLATED PROTEIN; LIPID; LOW DOSE ORAL CONTRACEPTIVE; NORGESTREL;

BLOOD AND HEMOPOIETIC SYSTEM; BLOOD LEVEL; DRUG DOSE; DRUG THERAPY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; HUMAN EXPERIMENT; LIVER; NORMAL HUMAN; THERAPY;

BIOLOGY; CONTRACEPTION; CONTRACEPTIVE AGENTS, ESTROGEN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE METHODS--ADMINISTRACTION AND DOSAGE; DISEASES; ENDOCRINE SYSTEM; ETHINYL ESTRADIOL--ADMINISTRACTION AND DOSAGE; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; HORMONES; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; LEVONORGESTREL--ADMINISTRACTION AND DOSAGE; LIPID METABOLIC EFFECTS--ANALYSIS; LIPIDS; METABOLIC EFFECTS; ORAL CONTRACEPTIVES, COMBINED--ADMINISTRACTION AND DOSAGE; ORAL CONTRACEPTIVES--ADMINISTRACTION AND DOSAGE; PHYSIOLOGY; REPRODUCTIVE CONTROL AGENTS;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOLIPOPROTEINS B; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; GLYCOPROTEINS; HUMAN; LEVONORGESTREL; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL CHOLESTEROL; NORGESTREL; NORPREGNENES; PROGESTATIONAL HORMONES, SYNTHETIC; STEREOISOMERISM; TRIGLYCERIDES;

EID: 0021229526     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(84)90079-9     Document Type: Article

References (33)

1. Oral contraceptives and cardiovascular disease
2. Effects of estrogens and progestogens on lipid metabolism
3. Carbohydrate metabolism prospectively studied in women using a low-estrogen oral contraceptive for six months
4. Carbohydrate metabolism during treatment with estrogen, progestogen and low-dose oral contraceptives
5. Progestogens in cardiovascular disease: An introduction to the epidemiologic data
6. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations
7. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol. Relationships to estrogen and progestin potency
8. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins
9. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive
10. Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers
11. Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins
12. Comparison of the metabolic effects of the two hormonal contraceptive methods An oral formulation and a vaginal ring II Serum lipoproteins and apolipoproteins
13. Effects on plasma apoproteins AI and B induced by two estro-progestin preparations: monophasic versus triphasic
14. High density lipoprotein cholesterol and apolipoprotein A-I levels in 32–33-year-old women on steroid contraceptives — differences between two frequently used low-estrogen pills
15. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay
16. Non-enzymatic glucosylation of serum proteins in diabetes mellitus
17. Simple turbidimetric method for the determination of serum cholesterol
18. Eine neue Bestimmung der Neutralfette im Blutserum and Gewebe
19. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
20. Determination of high-density lipoproteins. Screening methods compared
21. Comparison of the metabolic effects of desogestrel and of levonorgestrel in low-dose oestrogen oral contraceptives
22. Serum glycosylated proteins as a measure of carbohydrate metabolism in OC users
23. Effects of ethinylestradiol/D-norgestrel combinations on serum lipoproteins
24. Randomized prospective studies on metabolic effects of oral contraceptives
25. Comparative metabolic effects of oral contraceptives containing levonorgestrel or desogestrel
26. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: Differential changes in high-density lipoprotein subclasses
27. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen
28. Effects of four different oral contraceptives on serum lipids concentrations (Abstract)
29. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism
30. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease
31. Menopausal oestrogen therapy and protection from death from ischaemic heart disease
32. Effects of long-term estrogen replacement therapy
33. Estrogen use and cardiovascular mortality: the lipid research clinics follow-up study